Coulman SA - Search Results

1

Conjugation of a peptide autoantigen to gold nanoparticles for intradermally administered antigen specific immunotherapy.

Dul M, Nikolic T, Stefanidou M, McAteer MA, Williams P, Mous J, Roep BO, Kochba E, Levin Y, Peakman M, Wong FS, Dayan CM, Tatovic D, Coulman SA, Birchall JC; EE-ASI Consortium. Dul M, et al. Among authors: coulman sa. Int J Pharm. 2019 May 1;562:303-312. doi: 10.1016/j.ijpharm.2019.03.041. Epub 2019 Mar 22. Int J Pharm. 2019. PMID: 30910633

2

Cutaneous DNA delivery and gene expression in ex vivo human skin explants via wet-etch micro-fabricated micro-needles.

Birchall J, Coulman S, Pearton M, Allender C, Brain K, Anstey A, Gateley C, Wilke N, Morrissey A. Birchall J, et al. J Drug Target. 2005 Aug;13(7):415-21. doi: 10.1080/10611860500383705. J Drug Target. 2005. PMID: 16308210

3

Cutaneous gene expression of plasmid DNA in excised human skin following delivery via microchannels created by radio frequency ablation.

Birchall J, Coulman S, Anstey A, Gateley C, Sweetland H, Gershonowitz A, Neville L, Levin G. Birchall J, et al. Int J Pharm. 2006 Apr 7;312(1-2):15-23. doi: 10.1016/j.ijpharm.2005.12.036. Epub 2006 Feb 15. Int J Pharm. 2006. PMID: 16469457

4

Minimally invasive cutaneous delivery of macromolecules and plasmid DNA via microneedles.

Coulman SA, Barrow D, Anstey A, Gateley C, Morrissey A, Wilke N, Allender C, Brain K, Birchall JC. Coulman SA, et al. Curr Drug Deliv. 2006 Jan;3(1):65-75. doi: 10.2174/156720106775197510. Curr Drug Deliv. 2006. PMID: 16472095

5

Microneedles and other physical methods for overcoming the stratum corneum barrier for cutaneous gene therapy.

Coulman S, Allender C, Birchall J. Coulman S, et al. Crit Rev Ther Drug Carrier Syst. 2006;23(3):205-58. doi: 10.1615/critrevtherdrugcarriersyst.v23.i3.20. Crit Rev Ther Drug Carrier Syst. 2006. PMID: 17206925 Review.

6

Microneedle mediated delivery of nanoparticles into human skin.

Coulman SA, Anstey A, Gateley C, Morrissey A, McLoughlin P, Allender C, Birchall JC. Coulman SA, et al. Int J Pharm. 2009 Jan 21;366(1-2):190-200. doi: 10.1016/j.ijpharm.2008.08.040. Epub 2008 Sep 4. Int J Pharm. 2009. PMID: 18812218

7

Development of an ex vivo human skin model for intradermal vaccination: tissue viability and Langerhans cell behaviour.

Ng KW, Pearton M, Coulman S, Anstey A, Gateley C, Morrissey A, Allender C, Birchall J. Ng KW, et al. Vaccine. 2009 Oct 9;27(43):5948-55. doi: 10.1016/j.vaccine.2009.07.088. Epub 2009 Aug 11. Vaccine. 2009. PMID: 19679220 Free PMC article.

8

In vivo, in situ imaging of microneedle insertion into the skin of human volunteers using optical coherence tomography.

Coulman SA, Birchall JC, Alex A, Pearton M, Hofer B, O'Mahony C, Drexler W, Považay B. Coulman SA, et al. Pharm Res. 2011 Jan;28(1):66-81. doi: 10.1007/s11095-010-0167-x. Epub 2010 May 13. Pharm Res. 2011. PMID: 20464461 Clinical Trial.

9

Quantifying the mechanical properties of human skin to optimise future microneedle device design.

Groves RB, Coulman SA, Birchall JC, Evans SL. Groves RB, et al. Among authors: coulman sa. Comput Methods Biomech Biomed Engin. 2012;15(1):73-82. doi: 10.1080/10255842.2011.596481. Epub 2011 Jul 12. Comput Methods Biomech Biomed Engin. 2012. PMID: 21749225

10

Microneedle delivery of plasmid DNA to living human skin: Formulation coating, skin insertion and gene expression.

Pearton M, Saller V, Coulman SA, Gateley C, Anstey AV, Zarnitsyn V, Birchall JC. Pearton M, et al. Among authors: coulman sa. J Control Release. 2012 Jun 28;160(3):561-9. doi: 10.1016/j.jconrel.2012.04.005. Epub 2012 Apr 10. J Control Release. 2012. PMID: 22516089 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page